Effect of alendronate therapy in children with osteogenesis imperfecta

Joint Bone Spine

Volumn 72, Issue 5, 2005, Pages 416-423

  Vyskočil, Václav ^a   Pikner, Richard ^a   Kutílek, Štěpán ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alendronate; Osteogenesis imperfecta

Indexed keywords

ALENDRONIC ACID;

ADOLESCENT; ALLERGIC REACTION; ARTICLE; BONE INJURY; BONE PAIN; BONE PLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DRUG EFFECT; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; OSTEOGENESIS IMPERFECTA; RASH;

ADMINISTRATION, ORAL; ADOLESCENT; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; OSTEOGENESIS IMPERFECTA; TREATMENT OUTCOME;

EID: 26244455782     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2004.09.005     Document Type: Article

References (56)

1. H. Plotkin, D. Primorac, and D. Rowe Osteogenesis imperfecta F.H. Glorieux J.M. Pettifor H. Juppner Pediatric bone. Biology and diseases 2003 Academic Press San Diego 443 471
2. D.O. Sillence, A. Senn, and D.M. Danks Genetic heterogeneity in osteogenesis imperfecta J. Med. Genet. 16 1979 101 116
3. D. Sillence Osteogenesis imperfecta: an expanding panorama of variants Clin. Orthop. 159 1981 11 25
4. P.J. Roughley, F. Rauch, and F.H. Glorieux Osteogenesis imperfecta and molecular diversity Europ Cells Mater 5 2003 41 47
5. F. Rauch, and F.H. Glorieux Osteogenesis imperfecta Lancet 363 2004 1377 1385
6. G. Chevrel, and P.J. Meunier Osteogenesis imperfecta: lifelong management is imperative and feasible Joint Bone Spine 68 2001 125 129
7. F. Rauch, R. Travers, A.M. Parfitt, and F.H. Glorieux Static and dynamic bone histomorphometry in children with osteogenesis imperfecta Bone 26 2000 581 589
8. L. Zeitlin, F. Fassier, and F.H. Glorieux Modern approach to children with osteogenesis imperfecta J. Pediatr. Orthop. B 12 2003 77 87
9. F.H. Glorieux, N.J. Bishop, H. Plotkin, G. Chabot, G. Lanoue, and R. Travers Cyclic administration of pamidronate in children with severe osteogenesis imperfecta N. Engl. J. Med. 339 1998 947 952
10. M. Guillot, P. Eckart, H. Desrosiers, M. Amiour, and Z. Al-Jazayri Osteogenesis imperfecta: a new, early therapeutic approach with bisphosphonates. A case report Arch Pediatr 8 2001 172 175
11. F.H. Glorieux The use of bisphosphonates in children with osteogenesis imperfecta J Pediatr. Endocrinol. Metab. 14 2001 1491 1495
12. P. Orcel, and J. Beaudreuil Bisphosphonates in bone diseases other than osteoporosis Joint Bone Spine 69 2002 19 27
13. F. Rauch, R. Travers, H. Plotkin, and F.H. Glorieux The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta J. Clin. Invest. 110 2002 1293 1299
14. R. Lindsay Modeling the benefits of pamidronate in children with osteogenesis imperfecta J Clin Invest 110 2002 1239 1241
15. F. Rauch, H. Plotkin, L. Zeitlin, and F.H. Glorieux Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy J. Bone Miner. Res. 18 2003 610 614
16. L. Zeitlin, F. Rauch, H. Plotkin, and F.H. Glorieux Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV Pediatrics 111 2003 1030 1036
17. F. Rauch, H. Plotkin, R. Travers, L. Zeitlin, and F.H. Glorieux Osteogenesis imperfecta types I, III and IV: effect of pamidronate on bone and mineral metabolism J. Clin. Endocrinol. Metab. 88 2003 986 992
18. K. Montpetit, H. Plotkin, F. Rauch, N. Bilodeau, S. Cloutier, and M. Rabzel Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta Pediatrics 111 2003 601 603
19. M. Zacharin, and J. Bateman Pamidronate treatment of osteogenesis imperfecta -lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response J Pediatr Endocrinol Metab 15 2002 163 174
20. F. Giraud, and P.J. Meunier Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients Joint Bone Spine 69 2002 486 490
21. E. Astrom, and S. Soderhall Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta Arch. Dis. Child 87 2002 562 563
22. Z.S. Lee, S.L. Low, L.A. Lim, and K.Y. Loke Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta Eur. J. Pediatr. 160 2001 641 644
23. M.J. Falk, S. Heeger, K.A. Lynch, K.R. DeCaro, D. Bohach, and K.S. Gibson Intravenous bisphosphonate therapy in children with osteogenesis imperfecta Pediatrics 111 2003 573 578
24. E.A. Landsmeer-Beker, G.G. Massa, P.D. Maaswinkel-Mooy, J.J. Van:de:Kamp, and S.E. Papapoulos Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate Eur. J. Pediatr. 156 1997 792 794
25. M. Stuart Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children Clin. Pediatr. 41 2002 362 363
26. M.L. Bianchi, R. Cimaz, M. Bardare, F. Zulian, L. Lepore, and A. Boncompagni Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study Arthritis Rheum. 43 2000 1960 1966
27. R. Cimaz, M. Gattorno, M.P. Sormani, F. Falcini, F. Zulian, and L. Lepore Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases J. Rheumatol. 29 2002 1786 1792
28. F. Falcini, G. Bindi, G. Simonini, S. Stagi, F. Galluzzi, and L. Masi Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year follow-up study J. Rheumatol. 30 2003 179 184
29. L. Lhotská, P. Bláha, J. Vignerová, Z. Roth, and V.M. Prokopec Nation-wide anthropological survey of children and adolescents 1991 (Czech Republic) 1993 National Institute of Public Health Prague
30. H.P.J. Kroger Measurement of bone mass and density in children E. Schonau Paediatric osteology: new developments in diagnostics and therapy 1996 Elsevier Science Amsterdam 103 108
31. E.E. Bleck Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management Clin. Orthop. 159 1981 111 122
32. W. Jeal, L.B. Barradell, and D. McTavish Alendronate. A review of its pharmaceutical properties and therapeutic efficacy in postmenopausal osteoporosis Drugs 53 1997 415 434
33. E. Siris Alendronate in the treatment of osteoporosis: a review of the clinical trials J Woman Health Gender Based Med 9 2000 599 606
34. K.G. Saag, R. Emkey, T.J. Schnitzer, J.P. Brown, F. Hawkins, and S. Goemaere Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis N. Engl. J. Med. 339 1998 292 299
35. E. Demir, A. Bereket, B. Ozkan, and M. Topcu Effect of alendronate treatment on the clinical picture and bone turnover markers in chronic idiopathic hyperphosphatasia J. Pediatr. Endocrinol. Metab. 13 2000 217 221
36. V.V. Khadilkar, A.V. Khadilkar, and G.B. Maskati Oral bisphosphonates in polyostotic fibrous dysplasia Indian Pediatr. 40 2003 894 896
37. A. Bereket, and T. Erdogan Oral bisphosphonate therapy for vitamin D intoxication of the infant Pediatrics 111 2003 899 901
38. N.P. Camacho, C.L. Raggio, S.B. Doty, L. Root, V. Zraick, and W.A. Ilg A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta Calcif. Tissue Int. 69 2001 94 101
39. E. McCarthy, C.L. Raggio, M.D. Hossack, E.A. Miller, S. Jain, and A.L. Boskey Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model Pediatr. Res. 52 2002 660 670
40. M. Bayer, J.J. Stepan, and S. Kutilek Alendronate in treatment of osteoporosis in childhood (in Czech) Osteol. Bull. 7 2002 23 24
41. K. Maasalu, T. Haviko, and A. Martson Treatment of children with osteogenesis imperfecta in Estonia Acta Paediatr. 92 2003 452 455
42. S. Mora, L. Bachrach, and V. Gilsanz Noninvasive techniques for bone mass measurements F.H. Glorieux J.M. Pettifor H. Juppner Pediatric bone. Biology and diseases 2003 Academic Press San Diego 303 324
43. ISCD Position Development Conference WG Diagnosis of osteoporosis in men, premenopausal women, and children J. Clin. Densitom. 7 2004 17 26
44. D.R. Carter, M.L. Bouxsein, and R. Marcus New approaches for interpreting projected bone densitometry data J. Bone Miner. Res. 7 1992 137 145
45. B.L. Specker, N. Johannsen, T. Binkley, and K. Finn Total body bone mineral content and tibial cortical bone measures in school children J. Bone Miner. Res. 16 2001 2298 2305
46. H. Plotkin, M. Nunez, M.L. Alvarez:Filgueira, and J.R. Zanchetta Lumbar spine bone density in Argentine children Calcif. Tissue Int. 58 1996 144 149
47. R.E. Brenner, B. Schiller, U. Vetter, J. Ittner, and W.M. Teller Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis imperfecta Acta Paediatr. 82 1993 764 767
48. R.E. Brenner Collagen and bone markers in patients with osteogenesis imperfecta E. Schonau Paediatric osteology: new developments in diagnostics and therapy 1996 Elsevier Science Amsterdam 221 226
49. T. Srivastava, and U. Alon Bisphosphonates: from grandparents to grandchildren Clin. Pediatr. 38 1999 687 702
50. J. Allgrove Use of bisphosphonates in children and adolescents J. Pediatr. Endocrinol. Metab. 15 2002 921 928
51. I. Konne:Paut, J.M. Gennari, K. Retornaz, J.L. Jouve, and G. Bollini Bisphosphonates in children: present and future Arch. Pediatr. 9 2002 836 842
52. J.A. Batch, J.J. Couper, C. Rodda, C.T. Cowell, and M. Zacharin Use of bisphosphonate therapy for osteoporosis in childhood and adolescence J. Paediatr. Child Health 39 2003 88 92
53. L.E. Grissom, and H.T. Harcke Radiographic features of bisphosphonate therapy in pediatric patients Pediatr. Radiol. 33 2003 226 229
54. M.P. Whyte, D. Wenkert, K.L. Clements, W.H. McAlister, and S. Mumm Bisphosphonate-induced osteoporosis N. Engl. J. Med. 349 2003 457 463
55. J.C. Marini Do Bisphosphonates make children's bones better or brittle? N. Engl. J. Med. 349 2003 423 426
56. C. Brumsen, N.A. Hamdy, and S.E. Papapoulos Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis Medicine 76 1997 266 283